In addition, metabolic indices such as blood sugar and insulin levels are suggested to be biomarkers and to play important roles in the psychopathology of MDD and its treatment outcome [2,8,9], as MDD patients have a high risk of comorbid type 2 diabetes, obesity, and metabolic syndrome [10]. This evidence concerns the gene INS and major depressive disorder.